Aveanna Healthcare (NASDAQ:AVAH) Rating Lowered to "Buy" at Wall Street Zen

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued on Friday.

AVAH has been the subject of a number of other research reports. Truist Financial lowered their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th. UBS Group boosted their price objective on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $5.13.

Aveanna Healthcare Stock Performance

AVAH traded up $0.21 during trading on Friday, reaching $5.23. 688,443 shares of the company's stock were exchanged, compared to its average volume of 335,588. The company's fifty day moving average price is $5.13 and its 200-day moving average price is $4.87. Aveanna Healthcare has a fifty-two week low of $2.47 and a fifty-two week high of $6.19. The firm has a market capitalization of $1.02 billion, a PE ratio of 55.78 and a beta of 2.03.

Insiders Place Their Bets

In related news, CAO Deborah Stewart sold 15,457 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.56, for a total value of $85,940.92. Following the sale, the chief accounting officer directly owned 285,396 shares of the company's stock, valued at approximately $1,586,801.76. The trade was a 5.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Patrick A. Cunningham sold 18,500 shares of the business's stock in a transaction on Friday, June 13th. The shares were sold at an average price of $4.93, for a total transaction of $91,205.00. Following the completion of the sale, the insider directly owned 327,869 shares in the company, valued at $1,616,394.17. This represents a 5.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,120,925 shares of company stock worth $37,869,472 in the last ninety days. 7.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Rhumbline Advisers lifted its stake in shares of Aveanna Healthcare by 4.0% during the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after buying an additional 2,918 shares during the last quarter. Strs Ohio bought a new position in Aveanna Healthcare during the first quarter worth about $218,000. Acadian Asset Management LLC increased its position in Aveanna Healthcare by 9.2% during the first quarter. Acadian Asset Management LLC now owns 352,215 shares of the company's stock worth $1,902,000 after acquiring an additional 29,811 shares during the period. Jane Street Group LLC increased its position in Aveanna Healthcare by 522.0% during the first quarter. Jane Street Group LLC now owns 75,081 shares of the company's stock worth $407,000 after acquiring an additional 63,010 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in Aveanna Healthcare by 8.3% during the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company's stock worth $1,842,000 after acquiring an additional 25,974 shares during the period. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.